Physician CME

Retina Resource

30th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma - Learning Hub

Stay up to date with the latest advances in hematologic malignancies throug…

23rd Annual School of Breast Oncology® Curriculum

Joyce O’Shaughnessy, MD

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care Models

February 6, 2027

Oncology Town Hall: From Evidence to Action—Applying KRAS-Targeted Advances in Solid Tumors

July 14, 2026

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – New York

Lori A. Leslie, MD; Bachar Samra, MD

PER Global Perspectives: Preparing for the Emergence of TROP2 ADCs With Immunotherapy in the Earlier Treatment Settings

Solange Peters, MD, PhD; Myung-Ju Ahn, MD, PhD; Luis Paz-Ares, MD, PhD; Jac…

Rapid Reviews in Retina™: 2026 Updates – Episode 1: nAMD

Anat Loewenstein, MD

Houston Hematology Satellite Symposia

September 10, 2026

The Optometry Meeting in Anaheim

October 2, 2026

Oncology Town Hall: Updates From Berlin: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us

Hope S. Rugo, MD, FASCO; Fabrice André, MD, PhD; Heather McArthur, MD, MPH;…

Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

July 8, 2026

ADCs and Bispecific Antibodies Across Solid Tumors: Integrating New Targets, New Data, and New Decisions

William J. Gradishar, MD, FASCO, FACP; Rebecca Arend, MD, MSPH; Aaron Lisbe…

Medical Crossfire®: Precision Oncology in NSCLC – Translating HER2 and TROP2 Innovation into Practice-Changing Care

Benjamin P. Levy, MD; Sarah Goldberg, MD, MPH; Jacob Sands, MD; Helena Yu, …

Medical Crossfire®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma

Mohamad Mohty, MD, PhD; Shaji K. Kumar, MD; Suzanne Lentzsch, MD, PhD; Phil…

Hot Seat: Which Agent, and When? Integrating Next-Generation Endocrine Strategies Into HR+/HER2– Breast Cancer Management

Ruta D. Rao, MD; Kamel Abou Hussein, MD; Jame Abraham MD, FACP; Paolo Taran…

Cases and Conversations: Optimizing Oral SERD-Based Therapy After CDK4/6 Inhibition in HR+/HER2– MBC

Virginia Kaklamani, MD, DSc; Antonio Giordano, MD, PhD; Nadia Harbeck, MD, …

Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD

Tumor Board: Evolving Immunotherapy Strategies for Stage I-III NSCLC

Tina Cascone, MD, PhD; Puneeth Iyengar, MD, PhD; Paula A. Ugalde Figueroa, …

Show Me the Data™: Redefining Treatment Paradigms in Triple-Negative Breast Cancer Across the Disease Continuum

Hope S. Rugo, MD, FASCO; Neil M. Iyengar, MD; Heather McArthur, MD, MPH; Ja…

Medical Crossfire®: Closing Clinical Practice Gaps in Hepatobiliary Cancer With Emerging Immunotherapies and Delivery Innovations

Ghassan Abou-Alfa, MD, MBA; Riad Salem, MD, MBA; Rachna Shroff, MD, MS, FAS…

Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology

Enriqueta Felip, MD, PhD; Justin Gainor, MD; Julia Rotow, MD; Urs Weber, MD

Cases and Conversations: Applying the Evidence – Real-World Strategies to Optimize Care for Patients With Myelofibrosis

Ruben A. Mesa, MD, FACP; Andrew Kuykendall, MD; Sangeetha Venugopal, MD, MS

Live Tumor Board: Exploring Novel Targets and Breakthrough Treatment Strategies in Extrapulmonary Neuroendocrine Carcinomas

Aman Chauhan, MD, MBBS; Jonathan Strosberg, MD; Sylvia L. Asa, MD, PhD

Oncology Town Hall: Insights Reshaping How We Treat MPNs From the 2026 Summer Oncology Meetings

June 29, 2026

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Rhode Island

Yelda Nouri, MD; Sara Nunnery, MD, MSCI

Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas

Lori A. Leslie, MD; Alex Mejia, MD

Show Me the Data®: Evolving Standards and New Frontiers in Ovarian Cancer

Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Ritu Salani, MD,…

Cases and Conversations®: Advancing Diagnosis and Long-Term Management of CIDP

Karissa Gable, MD; Jeffrey Allen, MD; Suraj Muley, MD, FAAN

Live Tumor Board: Translating Biomarker Insights and Therapeutic Advances Into Endometrial Cancer Practice

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA; Casey Cosgrove, MD;…

The New DED Toolkit: Innovative Therapies Reshaping Dry Eye Management

Laura M. Periman, MD; Kristin Barnes, OD; Selina McGee, OD, FAAO, Dipl ABO;…

Primary Care Playbook: Advancing COVID-19 Prophylaxis in Community Practice

Chuck Vega, MD; Stefan Gravenstein MD, MPH

Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Ashley S. Margol, MD, M…

Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD; David M. Gershenson, MD; Ursula Matulonis, MD; David…

Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Wisconsin Association of Hematology and Oncology

Seth A. Wander, MD, PhD; Yang Liu, MD

Searching for Silence: Corneal Sensitivity Testing in NK

Francis Mah, MD; Amy Nau, OD , FAAO, Dipl. CCLRT

PER® Postgame™: Addressing the Unmet Medical Needs of Patients with Psoriasis—Summarizing the Latest Advancements in Oral Therapy

Jason E. Hawkes, MD, MS; Christopher G. Bunick, MD, PhD

Advancing Presbyopia Care: Patient-Centered Strategies for Pharmacologic Management

Brian Szabo, DO; Nick Bruns, OD, FAAO

Community Practice Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma

Lori A. Leslie, MD; Krish Patel, MD

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRC…

From Numbers to Navigation: Translating Data From Diabetes Technologies into Optimized Decision-Making

Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP; Robert H. Eckel, …

Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; Rachel N. Grisham, MD; Rohit Gupta, MD; M…

From Data to Decisions: Applying the Latest Evidence for New Targeted Therapies in HER2-Positive Gastroesophageal Adenocarcinoma

Pashtoon Kasi, MD, MS; Elizabeth Conner, MD; Simona De Michele, MD

Join Us at The Ophthalmology Meeting This October in New Orleans

October 9, 2026

Retina Updates in Montréal

July 16-17, 2026

Rapid Reviews in Retina™: Emerging Updates from Winter 2026 – Addressing the Wealth of New Data in Treatments for nAMD, DME, and RVO

Judy E. Kim, MD, FARVO, FASRS; Prethy Rao, MD, MPH, FACS

Rheumatology Winter Clinical Symposium 2027

February 10-13, 2027